InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,474.36
(
0.02%
)
US TECH 100
19,287.20
(
0.15%
)
Dow Jones
39,117.42
(
-0.04%
)
Brent Oil
84.49
(
-0.61%
)
Bitcoin
63,731.02
(
-1.67%
)
Post# of 216
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TREND1

Send PM Follow Ignore
Followers 416
Posts 52354
Boards Moderated 13
Alias Born 12/16/2001

TREND1

Member Level

Re: None

Monday, 11/14/2016 11:38:07 AM

Monday, November 14, 2016 11:38:07 AM

Post# of 216
MannKind - Afrezza Scripts Increase, Runway Extended, But Sales Will Still Be Problematic

Nov. 14, 2016 11:09 AM ET

Spencer Osborne

•Afrezza scripts sales increase to just under 300 for week ending November 4th.

•Company gets runway extended via settlement with Sanofi.

•Sales projections remain problematic, as does potential NASDAQ de-listing.


http://seekingalpha.com/article/4023137-mannkind-afrezza-scripts-increase-runway-extended-sales-will-still-problematic?app=1&auth_param=1vat:1c2jodq:2a881efeba16dead8182f523d30545a9&uprof=51

MAIN BOARD http://investorshub.advfn.com/TRADING-3X-TNA-TQQQ-SPXL-RUS-2000-FUTURES-12981/

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up